Market Overview:
The global anti-fatty acid synthase antibody market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of obesity and other lifestyle diseases, rising demand for better diagnostic tools, and technological advancements in the field of antibody research and development. Based on type, the global anti-fatty acid synthase antibody market can be segmented into human, mouse, rat, and other types. The human type segment is expected to account for the largest share of the global anti-fatty acid synthase antibody market in 2018. This segment is also projected to grow at a CAGR of 6.8% during the forecast period from 2018 to 2030.
Product Definition:
Anti-fatty acid synthase antibody is a protein that is produced by the body in response to the presence of fatty acid synthase (FAS). FAS is an enzyme that plays a role in the synthesis of fatty acids from simple molecules. The anti-fatty acid synthase antibody binds to FAS, preventing it from functioning properly. This can reduce the amount of fat synthesized by cells, leading to weight loss or prevention of weight gain. Anti-fatty acid synthase antibodies are used as a treatment for obesity and other conditions related to abnormal fat deposition.
Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027:
The global GAFAS (Glo-B1) antibody market was valued at USD 8.0 million in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The market growth can be attributed to the rising prevalence of obesity, which has led to an increase in demand for anti-fatty acid synthase antibodies for diagnostics as well as therapeutics purposes.
Human:
Human is a source of all the antibodies and it's used in antibody therapeutics. Antibodies are proteins made by B cells and they fight against diseases by attaching themselves to cancer or viruses. There are various types of antibodies such as immunoglobulin, Fab, F(ab)2, etc., which differ according to their specific functions.
Application Insights:
Medical application held the largest share of over 70.0% in 2021 and is expected to continue its dominance over the forecast period. This can be attributed to increasing prevalence of diseases such as obesity, diabetes, and cardiovascular diseases that are associated with altered metabolism of fatty acids.
The medical segment is further divided into two categories namely therapeutic and diagnostic applications. Therapeutic application includes use in the treatment or prevention of disease states where reducing fat intake reduces body weight without affecting food intake too much thereby improving health outcomes. On other hand, diagnostic applications include use in diagnosis or monitoring of various chronic disorders related to metabolism including obesity & diabetes mellitus type 2 as well as cardiovascular diseases & stroke which involves analysis on blood samples for measuring levels of Fatty Acid Synthase (FAS) enzyme activity which helps detect a condition ere FAS level is elevated indicating a disorder pertaining to this enzyme activity such as insulin resistance or Type 2 Diabetes Mellitus (T2DM).
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The presence of a large number of fatty acid synthase (FAS) inhibitors that are being used for treating obesity and related disorders is one major factor responsible for its largest revenue share. Favorable regulatory policies regarding the approval and commercialization of these drugs also contribute to its largest revenue share.
Asia Pacific is expected to be the fastest-growing region over the forecast period owing to rising disposable income, increasing prevalence of obesity, diabetes, cardiovascular diseases (CVDs), cancer, etc., which results into increased demand for anti-fatty acid synthaase antibody products from medical practitioners as well as research laboratories across this region. Moreover it has been observed that Asia Pacific countries have a high incidence rate associated with fatty liver disease due to their high consumption of unhealthy food items such as alcohol & beer; tobacco; fast foods; processed meats like chiken nuggets & burgers; French fries etc.
Growth Factors:
- Increasing prevalence of obesity and metabolic syndrome
- Growing awareness about the benefits of anti-fatty acid synthase antibodies
- Rising demand for antibody-based therapies for the treatment of obesity and metabolic syndrome
- Technological advancements in antibody discovery and development processes
- Growing investments by pharmaceutical companies in research and development of anti-fatty acid synthase antibodies
Scope Of The Report
Report Attributes
Report Details
Report Title
Anti-Fatty Acid Synthase Antibody Market Research Report
By Type
Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027, Human, Mouse, Rat
By Application
Medical, Research Laboratories, Other
By Companies
Merck, Abcam, GeneTex, Atlas Antibodies, Santa Cruz Biotechnology, Boster Bio, Abcepta
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Anti-Fatty Acid Synthase Antibody Market Report Segments:
The global Anti-Fatty Acid Synthase Antibody market is segmented on the basis of:
Types
Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027, Human, Mouse, Rat
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Research Laboratories, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Abcam
- GeneTex
- Atlas Antibodies
- Santa Cruz Biotechnology
- Boster Bio
- Abcepta
Highlights of The Anti-Fatty Acid Synthase Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027
- Human
- Mouse
- Rat
- By Application:
- Medical
- Research Laboratories
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anti-Fatty Acid Synthase Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anti-fatty acid synthase antibody is a type of antibody that recognizes and binds to the fatty acid synthase protein. Fatty acids are important molecules in the body, and they are used to create energy. Anti-fatty acid synthase antibodies can be helpful in diagnosing and treating conditions related to fatty acids, such as obesity or heart disease.
Some of the key players operating in the anti-fatty acid synthase antibody market are Merck, Abcam, GeneTex, Atlas Antibodies, Santa Cruz Biotechnology, Boster Bio, Abcepta.
The anti-fatty acid synthase antibody market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anti-Fatty Acid Synthase Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anti-Fatty Acid Synthase Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anti-Fatty Acid Synthase Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anti-Fatty Acid Synthase Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anti-Fatty Acid Synthase Antibody Market Size & Forecast, 2018-2028
4.5.1 Anti-Fatty Acid Synthase Antibody Market Size and Y-o-Y Growth
4.5.2 Anti-Fatty Acid Synthase Antibody Market Absolute $ Opportunity
Chapter 5 Global Anti-Fatty Acid Synthase Antibody Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anti-Fatty Acid Synthase Antibody Market Size Forecast by Type
5.2.1 Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027
5.2.2 Human
5.2.3 Mouse
5.2.4 Rat
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anti-Fatty Acid Synthase Antibody Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anti-Fatty Acid Synthase Antibody Market Size Forecast by Applications
6.2.1 Medical
6.2.2 Research Laboratories
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anti-Fatty Acid Synthase Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anti-Fatty Acid Synthase Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anti-Fatty Acid Synthase Antibody Analysis and Forecast
9.1 Introduction
9.2 North America Anti-Fatty Acid Synthase Antibody Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anti-Fatty Acid Synthase Antibody Market Size Forecast by Type
9.6.1 Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027
9.6.2 Human
9.6.3 Mouse
9.6.4 Rat
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anti-Fatty Acid Synthase Antibody Market Size Forecast by Applications
9.10.1 Medical
9.10.2 Research Laboratories
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anti-Fatty Acid Synthase Antibody Analysis and Forecast
10.1 Introduction
10.2 Europe Anti-Fatty Acid Synthase Antibody Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anti-Fatty Acid Synthase Antibody Market Size Forecast by Type
10.6.1 Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027
10.6.2 Human
10.6.3 Mouse
10.6.4 Rat
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anti-Fatty Acid Synthase Antibody Market Size Forecast by Applications
10.10.1 Medical
10.10.2 Research Laboratories
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anti-Fatty Acid Synthase Antibody Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anti-Fatty Acid Synthase Antibody Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anti-Fatty Acid Synthase Antibody Market Size Forecast by Type
11.6.1 Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027
11.6.2 Human
11.6.3 Mouse
11.6.4 Rat
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anti-Fatty Acid Synthase Antibody Market Size Forecast by Applications
11.10.1 Medical
11.10.2 Research Laboratories
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anti-Fatty Acid Synthase Antibody Analysis and Forecast
12.1 Introduction
12.2 Latin America Anti-Fatty Acid Synthase Antibody Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anti-Fatty Acid Synthase Antibody Market Size Forecast by Type
12.6.1 Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027
12.6.2 Human
12.6.3 Mouse
12.6.4 Rat
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anti-Fatty Acid Synthase Antibody Market Size Forecast by Applications
12.10.1 Medical
12.10.2 Research Laboratories
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anti-Fatty Acid Synthase Antibody Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anti-Fatty Acid Synthase Antibody Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anti-Fatty Acid Synthase Antibody Market Size Forecast by Type
13.6.1 Global Anti-Fatty Acid Synthase Antibody Market Size Growth Rate by Reactivity: 2016 VS 2021 VS 2027
13.6.2 Human
13.6.3 Mouse
13.6.4 Rat
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anti-Fatty Acid Synthase Antibody Market Size Forecast by Applications
13.10.1 Medical
13.10.2 Research Laboratories
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anti-Fatty Acid Synthase Antibody Market: Competitive Dashboard
14.2 Global Anti-Fatty Acid Synthase Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Abcam
14.3.3 GeneTex
14.3.4 Atlas Antibodies
14.3.5 Santa Cruz Biotechnology
14.3.6 Boster Bio
14.3.7 Abcepta
